Multiple myeloma is a hematological malignancy characterized by the unrestricted proliferation of plasma cells that secrete monoclonal immunoglobulins in the bone marrow. Alpha-momorcharin (α-MMC) is a type I ribosome-inactivating protein extracted from the seeds of the edible plant L., which has a variety of biological activities. This study aimed to investigate the inhibitory effect of α-MMC on the proliferation of multiple myeloma MM.1S cells and the molecular mechanism of MM.1S cell death induced through the activation of cell signal transduction pathways. The cell counting kit-8 (CCK-8) assay was used to determine the inhibitory effect of α-MMC on the proliferation of MM.1S cells and its toxic effect on normal human peripheral blood mononuclear cells (PBMCs). The effect of α-MMC on the MM.1S cells' morphology was observed via inverted microscope imaging. The effects of α-MMC on the MM.1S cell cycle, mitochondrial membrane potential (MMP), and apoptosis were explored using propidium iodide, JC-1, annexin V- fluorescein isothiocyanate/propidium iodide fluorescence staining, and flow cytometry (FCM) analysis. Western blot was used to detect the expressions levels of apoptosis-related proteins and MAPK-signaling-pathway-related proteins in MM.1S cells induced by α-MMC. The results of the CCK-8 showed that in the concentration range of no significant toxicity to PBMCs, α-MMC inhibited the proliferation of MM.1S cells in a time-dependent and concentration-dependent manner, and the IC value was 13.04 and 7.518 μg/mL for 24 and 48 h, respectively. Through inverted microscope imaging, it was observed that α-MMC induced a typical apoptotic morphology in MM.1S cells. The results of the FCM detection and analysis showed that α-MMC could arrest the MM.1S cells cycle at the G2 phase, decrease the MMP, and induce cell apoptosis. Western blot analysis found that α-MMC upregulated the expression levels of Bax, Bid, cleaved caspase-3, and cleaved PARP, and downregulated the expression levels of Mcl-1. At the same time, α-MMC decreased the expression levels of p-c-Raf, p-MEK1/2, p-ERK1/2, p-MSK1, and p-P90RSK, and increased the expression levels of p-p38, p-SPAK/JNK, p-c-Jun, and p-ATF2. The above results suggest that α-MMC can inhibit the proliferation of multiple myeloma MM.1S cells. MAPK cascade signaling is involved in the growth inhibition effect of α-MMC on MM.1S cells via cycle arrest and mitochondrial-pathway-dependent apoptosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867419PMC
http://dx.doi.org/10.3390/ph16010124DOI Listing

Publication Analysis

Top Keywords

mm1s cells
36
multiple myeloma
16
expression levels
16
α-mmc
14
mm1s
12
myeloma mm1s
12
α-mmc mm1s
12
cells
11
mapk cascade
8
cascade signaling
8

Similar Publications

Reduced elastin in multiple myeloma niche promotes cell proliferation.

Exp Cell Res

January 2025

Oncogenetics Laboratory, Meir Medical Center, Tchernichovsky St 59, Kfar Saba, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, PO Box 39040, Tel Aviv, Tel Aviv, Israel. Electronic address:

Multiple myeloma (MM) malignant plasma cells accumulate in the bone marrow (BM) where their interactions with the microenvironment promote disease progression and drug resistance. Previously, we have shown that bone marrow mesenchymal stem cells (BM-MSCs) (MM and normal donors- ND) derived extracellular matrix (ECM) affected MM cell lines differentially with a pro-MM effect attributed to MM-MSCs' ECM. Here we studied the composition of BM-MSC's ECM (ND versus MM) with focus on elastin (ELN).

View Article and Find Full Text PDF

Unveiling the Correlation Between the Membrane Assembly of P-gp and Drug Resistance in Multiple Myeloma Using Super-Resolution Fluorescence Imaging.

Anal Chem

July 2024

State Key Laboratory of Electroanalytical Chemistry, Research Center of Biomembranomics, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Street, Changchun, Jilin 130022, China.

Article Synopsis
  • Drug resistance in multiple myeloma (MM) is significantly influenced by the dysfunction of P-glycoprotein (P-gp), and this study investigates its spatial organization to better understand its role in treatment resistance.
  • Using advanced imaging techniques, the research found that drug-resistant MM cells (MM1R) have a greater clustering of P-gp on their surfaces compared to drug-sensitive cells (MM1S), especially under low oxygen (hypoxic) conditions.
  • The study also highlighted that changes in P-gp clustering, influenced by membrane carbohydrates and treatments like dexamethasone, can potentially modulate drug responsiveness, providing new avenues for improving treatment strategies in MM.
View Article and Find Full Text PDF

[Mechanism and Clinical Significance of in Multiple Myeloma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

February 2024

Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China.E-mail:

Article Synopsis
  • The study aims to explore how nicotinamide phosphoribosyltransferase (NAMPT) functions and its potential clinical significance in multiple myeloma (MM).
  • Researchers used techniques like RT-qPCR and Western blot to analyze NAMPT expression in MM cells and normal cells, investigating its role in cell growth and death.
  • Results showed that NAMPT levels were significantly higher in MM cells, promoting cell growth and inhibiting death, with its expression regulated by the IRE1α-XBP1 signaling pathway, which influences how susceptible these cells are to the treatment drug bortezomib.
View Article and Find Full Text PDF
Article Synopsis
  • Overexpression of inhibitor of apoptosis (IAP) proteins is linked to poor outcomes in multiple myeloma (MM), prompting research into IAP inhibitors (IAPi) for treatment.
  • While existing inhibitors like LCL161 are not fully effective, a new compound, AZD5582, shows strong binding to XIAP, leading to better anti-cancer activity in MM cell lines by inducing apoptosis and inhibiting growth.
  • AZD5582 also demonstrates enhanced effectiveness when combined with existing therapies, suggesting its potential as a promising monotherapy and in combination strategies for treating MM.
View Article and Find Full Text PDF

The cause of hematological cancers is the uncontrolled proliferation of hematopoietic and lymphoid tissues, and chemotherapy is used to treat cancer. However, adverse side effects of chemotherapy are common. Therefore, the use of plant extracts as a method for treating cancer is becoming increasingly popular.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!